Palisade Bio Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, Palisade Bio stock has a consensus rating of "Strong Buy" and an average price target of $10.22. The average 1-year stock price forecast is 604.83% higher than the current stock price, while the lowest is $5.00 (+244.83%) and the highest is $25 (+1,624.14%).

Price Target: $10.22 (+604.83%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$5.00	$10.22	$8.00	$25
Change	+244.83%	+604.83%	+451.72%	+1624.1%

Analyst Ratings

The average analyst rating for Palisade Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	5	6	7	7	7	7
Buy	2	2	2	2	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	8	9	9	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst Raymond James No rating	Raymond James	Buy Initiates $6	Buy	Initiates	$6	+313.79%	Oct 8, 2026
Yasmeen Rahimi Piper Sandler	Piper Sandler	Buy Maintains $25	Buy	Maintains	$25	+1,624.14%	Sep 24, 2026
Mitchell Kapoor H.C. Wainwright	H.C. Wainwright	Buy Reiterates $7	Buy	Reiterates	$7	+382.76%	Sep 23, 2026
Naz Rahman Maxim Group	Maxim Group	Buy Reiterates $8	Buy	Reiterates	$8	+451.72%	Aug 12, 2026
Unknown Analyst B. Riley Securities No rating	B. Riley Securities	Buy Initiates $7	Buy	Initiates	$7	+382.76%	Aug 12, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

357.14K

Revenue Next Year

n/a

from 357.14K

-100.00%

from 357.14K

EPS This Year

-0.23

from -0.30

EPS Next Year

-0.28

from -0.23

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	250.00K	-	-	357.14K
Gross Profit	-	-	250.00K	-	-	321.43K
Gross Margin	-	-	100.00%	-	-	90.00%
Operating Income	-11.74M	-15.31M	-12.85M	-14.86M	-18.06M	-51.22M
Net Income	-26.62M	-14.26M	-12.30M	-14.44M	-16.78M	-47.86M
EPS	-	-	-	-	-0.30	-0.23
Free Cash Flow	-	-	-	-	-10.85M	-39.70M
No. Analysts	-	-	-	-	-	7

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	500,000
Avg	357,140
Low	n/a

Revenue Growth

Chart

Revenue Growth	2027	2028
High	-100.0%
Avg	-100.0%
Low	-100.0%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-0.20
Avg	-0.23
Low	-0.25

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-